Published in Am J Hum Genet on September 27, 2001
Vascular extracellular matrix and arterial mechanics. Physiol Rev (2009) 3.05
Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis (2007) 2.28
Familial thoracic aortic aneurysms and dissections: identification of a novel locus for stable aneurysms with a low risk for progression to aortic dissection. Circ Cardiovasc Genet (2010) 1.55
G protein-coupled receptor 56 and collagen III, a receptor-ligand pair, regulates cortical development and lamination. Proc Natl Acad Sci U S A (2011) 1.53
Aortic disease in the young: genetic aneurysm syndromes, connective tissue disorders, and familial aortic aneurysms and dissections. Int J Vasc Med (2013) 1.29
Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke. Dis Model Mech (2008) 1.23
Diminished type III collagen promotes myofibroblast differentiation and increases scar deposition in cutaneous wound healing. Cells Tissues Organs (2011) 1.19
The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome. Vet Pathol (2010) 0.94
Cerebrovascular Involvement in Ehlers-Danlos Syndrome. Curr Treat Options Cardiovasc Med (2004) 0.93
Homozygosity for a null allele of COL3A1 results in recessive Ehlers-Danlos syndrome. Eur J Hum Genet (2009) 0.92
COL3A1 2209G>A is a predictor of pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.90
Spontaneous rupture of the spleen in type IV Ehlers-Danlos syndrome: report of a case. Surg Today (2009) 0.89
Loss of Col3a1, the gene for Ehlers-Danlos syndrome type IV, results in neocortical dyslamination. PLoS One (2012) 0.88
GPR56 and the developing cerebral cortex: cells, matrix, and neuronal migration. Mol Neurobiol (2012) 0.88
Vascular Ehlers-Danlos syndrome mutations in type III collagen differently stall the triple helical folding. J Biol Chem (2013) 0.88
Hemizygous deletion of COL3A1, COL5A2, and MSTN causes a complex phenotype with aortic dissection: a lesson for and from true haploinsufficiency. Eur J Hum Genet (2010) 0.87
Haploinsufficiency of the murine Col3a1 locus causes aortic dissection: a novel model of the vascular type of Ehlers-Danlos syndrome. Cardiovasc Res (2010) 0.85
Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndrome. J Pharmacol Exp Ther (2011) 0.84
The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome. Eur J Hum Genet (2015) 0.83
A functional variant of the collagen type III alpha1 gene modify risk of sporadic intracranial aneurysms. Hum Genet (2012) 0.82
Collagen expression in fibroblasts with a novel LMNA mutation. Biochem Biophys Res Commun (2006) 0.82
Allele-specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers-Danlos syndrome in human fibroblasts. FASEB J (2011) 0.81
Gene panel sequencing in heritable thoracic aortic disorders and related entities - results of comprehensive testing in a cohort of 264 patients. Orphanet J Rare Dis (2015) 0.79
TCRzeta mRNA splice variant forms observed in the peripheral blood T cells from systemic lupus erythematosus patients. Springer Semin Immunopathol (2006) 0.79
Differences between Mice and Humans in Regulation and the Molecular Network of Collagen, Type III, Alpha-1 at the Gene Expression Level: Obstacles that Translational Research Must Overcome. Int J Mol Sci (2015) 0.78
Delineation of 2q32q35 deletion phenotypes: two apparent "proximal" and "distal" syndromes. Case Rep Genet (2013) 0.76
Identification of EGFLAM, SPATC1L and RNASE13 as novel susceptibility loci for aortic aneurysm in Japanese individuals by exome-wide association studies. Int J Mol Med (2017) 0.75
A combined vascular surgical and clinical genetics approach to diffuse aneurysmal disease. Ann R Coll Surg Engl (2015) 0.75
Vascular Ehlers-Danlos syndrome: exploring the role of inflammation in arterial disease. Circ Cardiovasc Genet (2014) 0.75
Understanding vascular-type Ehlers-Danlos syndrome and avoiding vascular complications. Proc (Bayl Univ Med Cent) (2017) 0.75
N-(2-Aminoethyl) Ethanolamine-Induced Morphological, Biochemical, and Biophysical Alterations in Vascular Matrix Associated With Dissecting Aortic Aneurysm. Toxicol Sci (2015) 0.75
Presymptomatic genetic analysis during pregnancy for vascular type Ehlers-Danlos syndrome. Int Med Case Rep J (2014) 0.75
Aetiology and management of hereditary aortopathy. Nat Rev Cardiol (2017) 0.75
Prediction and Analysis of Key Genes in Glioblastoma Based on Bioinformatics. Biomed Res Int (2017) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet (1998) 7.68
Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med (2000) 7.61
The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions. EMBO J (2000) 7.54
Human Upf proteins target an mRNA for nonsense-mediated decay when bound downstream of a termination codon. Cell (2000) 5.54
Collagen fibril formation. Biochem J (1996) 4.35
Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand Suppl (1995) 3.52
Quality control of mRNA function. Cell (2001) 3.44
Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. J Biol Chem (1985) 2.45
Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A (1997) 2.37
Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing. Proc Natl Acad Sci U S A (1998) 2.14
Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I. J Clin Invest (1990) 1.61
Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains. Am J Hum Genet (1996) 1.59
Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet (1994) 1.51
mRNA quality control: Marking the message for life or death. Curr Biol (2001) 1.47
Inheritance of Ehlers-Danlos type IV syndrome. J Med Genet (1977) 1.47
Interaction between collagen type I and type III in conditioning bundles organization. Connect Tissue Res (1977) 1.25
Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: influence of intron splice order on outcome of splice-site mutation. Am J Hum Genet (1999) 1.24
COL3A1 mutations cause variable clinical phenotypes including acrogeria and vascular rupture. Br J Dermatol (1996) 1.22
Cloning and analysis of the 5' portion of the human type-III procollagen gene (COL3A1). Gene (1989) 1.21
Clinical presentations of Ehlers Danlos syndrome type IV. Arch Dis Child (1988) 1.18
Copolymerization of pNcollagen III and collagen I. pNcollagen III decreases the rate of incorporation of collagen I into fibrils, the amount of collagen I incorporated, and the diameter of the fibrils formed. J Biol Chem (1991) 1.14
COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS. Am J Hum Genet (2000) 1.12
EDS IV (acrogeria): new autosomal dominant and recessive types. J R Soc Med (1980) 1.12
Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II). Am J Hum Genet (2000) 1.11
Sequencing of cDNA from 50 unrelated patients reveals that mutations in the triple-helical domain of type III procollagen are an infrequent cause of aortic aneurysms. J Clin Invest (1993) 1.11
Splicing defects in the COL3A1 gene: marked preference for 5' (donor) spice-site mutations in patients with exon-skipping mutations and Ehlers-Danlos syndrome type IV. Am J Hum Genet (1997) 1.10
Defective splicing of mRNA from one COL1A1 allele of type I collagen in nondeforming (type I) osteogenesis imperfecta. J Clin Invest (1993) 1.06
Nuclear retention of COL1A1 messenger RNA identifies null alleles causing mild osteogenesis imperfecta. J Clin Invest (1996) 1.04
Thirty-three novel COL1A1 and COL1A2 mutations in patients with osteogenesis imperfecta types I-IV. Hum Mutat (2001) 1.02
G to A polymorphism in exon 31 of the COL3A1 gene. Nucleic Acids Res (1990) 0.91
Molecular diagnosis of Stickler syndrome: a COL2A1 stop codon mutation screening strategy that is not compromised by mutant mRNA instability. Am J Med Genet (2000) 0.87
C to T polymorphism in exon 33 of the COL3A1 gene. Nucleic Acids Res (1991) 0.83
Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med (2000) 7.61
Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36
Primary venous leiomyosarcoma: a rare but lethal disease. J Vasc Surg (1992) 3.05
Correlation of procollagen mRNA levels in normal and transformed chick embryo fibroblasts with different rates of procollagen synthesis. Biochemistry (1978) 2.85
Defect in conversion of procollagen to collagen in a form of Ehlers-Danlos syndrome. Science (1973) 2.74
Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II. Nature (1985) 2.46
Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen. Proc Natl Acad Sci U S A (1982) 2.45
Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. J Biol Chem (1985) 2.45
Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results. J Vasc Surg (2001) 2.43
Production of procollagen by human fibroblasts in culture. Proc Natl Acad Sci U S A (1972) 2.30
Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta. Proc Natl Acad Sci U S A (1981) 2.28
Penetration of the skull base by dissecting keratocyst. J Craniomaxillofac Surg (1993) 2.16
Surgical treatment of venous malformations in Klippel-Trénaunay syndrome. J Vasc Surg (2000) 2.12
Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg (2008) 2.10
Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. Am J Hum Genet (1999) 1.98
Headache and neck pain in spontaneous internal carotid and vertebral artery dissections. Neurology (1995) 1.96
Preparation of type III procollagen and collagen from rat skin. Biochemistry (1974) 1.92
Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg (1994) 1.86
Spontaneous multivessel cervical artery dissection in a patient with a substitution of alanine for glycine (G13A) in the alpha 1 (I) chain of type I collagen. Neurology (1996) 1.85
Cysteine in the triple-helical domain of one allelic product of the alpha 1(I) gene of type I collagen produces a lethal form of osteogenesis imperfecta. J Biol Chem (1984) 1.84
The bicuspid aortic valve: an integrated phenotypic classification of leaflet morphology and aortic root shape. Heart (2008) 1.81
Cranial nerve palsy in spontaneous dissection of the extracranial internal carotid artery. Neurology (1996) 1.81
Marfan syndrome: abnormal alpha 2 chain in type I collagen. Proc Natl Acad Sci U S A (1981) 1.78
BiP binds type I procollagen pro alpha chains with mutations in the carboxyl-terminal propeptide synthesized by cells from patients with osteogenesis imperfecta. J Biol Chem (1993) 1.72
Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta. J Clin Invest (1983) 1.71
Aorto-caval and ilio-iliac arteriovenous fistulae. Am J Surg (1998) 1.70
Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts. J Clin Invest (1992) 1.68
Identification of the collagenous proteins synthesized by cultured cells from human skin. Biochemistry (1975) 1.67
Replacement of the inferior vena cava for malignancy: an update. J Vasc Surg (2000) 1.66
Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele. Proc Natl Acad Sci U S A (1986) 1.65
Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene. Am J Med Genet (1996) 1.65
Trends in neurovascular complications of surgical management for carotid body and cervical paragangliomas: a fifty-year experience with 153 tumors. J Vasc Surg (1988) 1.62
X-linked cutis laxa: defective cross-link formation in collagen due to decreased lysyl oxidase activity. N Engl J Med (1980) 1.62
Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I. J Clin Invest (1990) 1.61
Renal artery stent revascularization with embolic protection in patients with ischemic nephropathy. Kidney Int (2006) 1.61
Osteogenesis imperfecta: update and perspective. Am J Med Genet (1984) 1.60
Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta. Am J Hum Genet (1990) 1.56
Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1). Am J Hum Genet (1990) 1.54
Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J Med Genet (2009) 1.53
Intron-mediated recombination may cause a deletion in an alpha 1 type I collagen chain in a lethal form of osteogenesis imperfecta. Proc Natl Acad Sci U S A (1985) 1.53
Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet (1994) 1.51
Changing incidence of abdominal aortic aneurysms: a population-based study. Am J Epidemiol (1984) 1.50
Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta. J Biol Chem (1993) 1.49
Isolated iliac artery aneurysms. Surgery (1983) 1.49
NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight. Neurology (2007) 1.47
Klippel-Trenaunay syndrome: the risks and benefits of vascular interventions. Surgery (1991) 1.47
Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent. Am J Hum Genet (1990) 1.47
Aortic fenestration for acute or chronic aortic dissection: an uncommon but effective procedure. J Vasc Surg (2000) 1.46
Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts. Lab Invest (1981) 1.46
A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito. Nat Genet (1996) 1.46
Complement as a mediator of inflammation in acute gouty arthritis. I. Studies on the reaction between human serum complement and sodium urate crystals. J Lab Clin Med (1973) 1.45
Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype. J Clin Invest (1989) 1.45
Perimesencephalic nonaneurysmal subarachnoid hemorrhage: first hint of a cause? Neurology (1997) 1.45
Abdominal aortic aneurysms: the changing natural history. J Vasc Surg (1984) 1.42
Myocardial revascularization before abdominal aortic aneurysmorrhaphy: effect of coronary angioplasty. Mayo Clin Proc (1993) 1.40
Late survival after abdominal aortic aneurysm repair: influence of coronary artery disease. J Vasc Surg (1984) 1.38
Management of true aneurysms distal to the axillary artery. J Vasc Surg (1998) 1.37
Procollagen. Adv Enzymol Relat Areas Mol Biol (1975) 1.37
Inflammatory abdominal aortic aneurysms: a thirty-year review. J Vasc Surg (1985) 1.37
Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome. Lab Invest (1979) 1.36
Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen. Am J Hum Genet (1992) 1.35
Heterozygosity for a large deletion in the alpha 2(I) collagen gene has a dramatic effect on type I collagen secretion and produces perinatal lethal osteogenesis imperfecta. J Biol Chem (1988) 1.34
Reconstruction of the vena cava and of its primary tributaries: a preliminary report. J Vasc Surg (1990) 1.32
Clinical and ultrastructural heterogeneity of type IV Ehlers-Danlos syndrome. Hum Genet (1979) 1.31
Studies of collagen synthesis and structure in the differentiation of child abuse from osteogenesis imperfecta. J Pediatr (1996) 1.29
Ischemic injury to the spinal cord or lumbosacral plexus after aorto-iliac reconstruction. Am J Surg (1991) 1.27
Aortic root complications in Marfan's syndrome: identification of a lower risk group. Heart (1996) 1.27
Genetics of tuberous sclerosis. Lancet (1987) 1.27
Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen. Am J Hum Genet (1992) 1.25
The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery (1998) 1.24
Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: influence of intron splice order on outcome of splice-site mutation. Am J Hum Genet (1999) 1.24
Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV. Hum Genet (1989) 1.24
Inflammatory abdominal aortic aneurysms: a case-control study. J Vasc Surg (1996) 1.23
Arginine for glycine substitution in the triple-helical domain of the products of one alpha 2(I) collagen allele (COL1A2) produces the osteogenesis imperfecta type IV phenotype. J Biol Chem (1988) 1.22
Genetic disorders of collagen metabolism. Adv Hum Genet (1982) 1.22
Structural abnormalities in the dermal collagen and elastic matrix from the skin of patients with inherited connective tissue disorders. J Invest Dermatol (1982) 1.22
Peptide mapping of collagen chains using CNBr cleavage of proteins within polyacrylamide gels. Coll Relat Res (1981) 1.21
Surgical reconstruction of iliofemoral veins and the inferior vena cava for nonmalignant occlusive disease. J Vasc Surg (2001) 1.20
Family studies in tuberous sclerosis. evaluation of apparently unaffected parents. JAMA (1983) 1.17
Noninvasive evaluation of the swollen extremity: experiences with 190 lymphoscintigraphic examinations. J Vasc Surg (1989) 1.17
Pregnancy complications in type IV Ehlers-Danlos Syndrome. Lancet (1983) 1.16
Familial intracranial aneurysms. A review. Stroke (1992) 1.16
Graft-related complications after abdominal aortic aneurysm repair: reassurance from a 36-year population-based experience. J Vasc Surg (1997) 1.15
Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation (2001) 1.15
Interchain disulfide bonds in procollagen are located in a large nontriple-helical COOH-terminal domain. Proc Natl Acad Sci U S A (1975) 1.14
Cerebrovascular complications in Ehlers-Danlos syndrome type IV. Ann Neurol (1995) 1.14
Abdominal aortic aneurysm repair combined with a second surgical procedure--morbidity and mortality. Surgery (1984) 1.14
Ehlers-Danlos syndrome type IV: cosegregation of the phenotype to a COL3A1 allele of type III procollagen. Hum Genet (1986) 1.14
Recurrent aneurysms and late vascular complications following repair of abdominal aortic aneurysms. Arch Surg (1985) 1.14
Defective folding and stable association with protein disulfide isomerase/prolyl hydroxylase of type I procollagen with a deletion in the pro alpha 2(I) chain that preserves the Gly-X-Y repeat pattern. J Biol Chem (1992) 1.13
Role of common gene variations in the molecular pathogenesis of short-chain acyl-CoA dehydrogenase deficiency. Pediatr Res (2001) 1.13
Reconstruction of large veins for nonmalignant venous occlusive disease. J Vasc Surg (1992) 1.12
Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II). Am J Hum Genet (2000) 1.11
A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases. J Med Genet (2002) 1.11